These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18006377)

  • 21. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.
    Murphy NF; O'Loughlin C; Ledwidge M; McCaffrey D; McDonald K
    Eur J Heart Fail; 2007 Dec; 9(12):1196-204. PubMed ID: 18039520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart failure with normal left ventricular ejection fraction may be due to systolic dysfunction.
    Maciver DH
    J Am Coll Cardiol; 2009 Jul; 54(5):488; author reply 488-9. PubMed ID: 19628127
    [No Abstract]   [Full Text] [Related]  

  • 24. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months.
    Tremel F; Pépin JL; Veale D; Wuyam B; Siché JP; Mallion JM; Lévy P
    Eur Heart J; 1999 Aug; 20(16):1201-9. PubMed ID: 10448029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction.
    Maeder M; Ammann P; Kiowski W; Rickli H
    Eur J Heart Fail; 2005 Dec; 7(7):1164-7. PubMed ID: 16202651
    [No Abstract]   [Full Text] [Related]  

  • 26. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches.
    J Card Fail; 1999 Dec; 5(4):357-82. PubMed ID: 10634677
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy of patients hospitalized for heart failure with abnormal versus normal left ventricular ejection fraction.
    Sule S; Aronow WS
    Compr Ther; 2009; 35(1):50-4. PubMed ID: 19351105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
    Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
    Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction.
    Bitter T; Faber L; Hering D; Langer C; Horstkotte D; Oldenburg O
    Eur J Heart Fail; 2009 Jun; 11(6):602-8. PubMed ID: 19468022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Device therapy for the management of advanced heart failure.
    Krishnamani R; DeNofrio D
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):573-80. PubMed ID: 15225116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ejection fraction in heart failure.
    Sanderson JE
    Am J Cardiol; 2010 Jun; 105(12):1844-5; author reply 1845. PubMed ID: 20538143
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
    Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
    J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertrophy due to left cardiac insufficiency: role of the neurohumoral system].
    Lerch R; Montessuit C
    Praxis (Bern 1994); 1997 Feb; 86(7):238-41. PubMed ID: 9139340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of aldosterone blockade in heart failure.
    Pitt B
    Heart Fail Clin; 2005 Apr; 1(1):49-56. PubMed ID: 17386833
    [No Abstract]   [Full Text] [Related]  

  • 35. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.
    Cha YM; Redfield MM; Shen WK; Gersh BJ
    Circulation; 2004 Jun; 109(23):2839-43. PubMed ID: 15197156
    [No Abstract]   [Full Text] [Related]  

  • 38. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).
    Lam CS; Solomon SD
    Eur J Heart Fail; 2014 Oct; 16(10):1049-55. PubMed ID: 25210008
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.
    Sahay S; Khirfan G; Tonelli AR
    Respir Med; 2017 Oct; 131():94-100. PubMed ID: 28947049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal Muscle Compensation for Cardiac Muscle Insufficiency in Heart Failure and Reduced Ejection Fraction.
    Reddy YNV; Obokata M; Haykowsky MJ; Borlaug BA
    Circ Heart Fail; 2018 Jan; 11(1):e004714. PubMed ID: 29317402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.